T1958 |
AZ20
|
1233339-22-4
|
98.02%
|
|
AZ20 is an effective and specific inhibitor of ATR kinase (IC50: 5 nM, in a cell-free assay), 8-fold selectivity over mTOR.
|
T2357 |
GSK1059615
|
958852-01-2
|
98%
|
|
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
|
T3705 |
GDC0084
|
1382979-44-3
|
98%
|
|
GDC0084 (RG7666) is a PI3K inhibitor with potential antineoplastic activity. GDC0084 (RG7666) specifically inhibits PI3K in the PI3K/AKT kinase (or protein kinas...
|
T2083 |
PI-3065
|
955977-50-1
|
98%
|
|
PI-3065 is a novel potent and selective PI3K p110δ inhibitor.
|
T7166 |
GNE-493
|
1033735-94-2
|
98%
|
|
GNE-493 is potent, selective, and orally available PI3K and mTOR inhibitor with potential anticancer activity.IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for ...
|
T6820 |
D-α-Hydroxyglutaric acid disodium
|
103404-90-6
|
98%
|
|
D-α-Hydroxyglutaric acid disodium (Disodium (R)-2-Hydroxyglutarate) is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases with Ki of 0.628 mM.
|
T1859 |
AZD-8055
|
1009298-09-2
|
98%
|
|
AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms.
|
T6319 |
OSI-027
|
936890-98-1
|
98%
|
|
OSI-027 (ASP4786) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTO...
|
T6334 |
Ridaforolimus
|
572924-54-0
|
98%
|
|
Ridaforolimus (AP23573) is a small molecule and non-prodrug analogue of the lipophilic macrolide antibiotic rapamycin with potential antitumor activity. Ridaforo...
|
T1961 |
Vistusertib
|
1009298-59-2
|
97.94%
|
|
Vistusertib (AZD2014) is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity.
|
T9314 |
CC214-1
|
1021920-32-0
|
97.87%
|
|
CC214-1 is an mTOR inhibitor with potential anticancer activity, inhibits protein translation, and induces autophagy. CC214-1 is an in vitro tool compound for ex...
|
T2974 |
Cyclovirobuxine D
|
860-79-7
|
97.78%
|
|
Cyclovirobuxine D (Bebuxine) is extracted from Buxus microphylla.
|
T1908 |
MHY1485
|
326914-06-1
|
97.74%
|
|
MHY1485 is a mTOR activator. It inhibits the autophagic process by inhibition of fusion between autophagosomes and lysosomes, leading to the accumulation of LC3I...
|
T6354 |
(+)-Usnic acid
|
7562-61-0
|
97.61%
|
|
(+)-Usnic acid (D-Usnic Acid) is a naturally occurring dibenzofuran derivative found in several lichen species.
|
T4423 |
LY 303511 hydrochloride
|
2070014-90-1
|
97.44%
|
|
LY 303511 hydrochloride is a potent mTOR inhibitor
|
TN1405 |
Arnicolide D
|
34532-68-8
|
96.66%
|
|
Arnicolide D is a sesquiterpene lactone. Arnicolide D isolates from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling path...
|
T14033 |
3BDO
|
890405-51-3
|
96.00%
|
|
3BDO is an activator of mTOR. It can also inhibit autophagy..
|
T6072L |
BGT226
|
915020-55-2
|
95.74%
|
|
BGT226 (NVP-BGT226) is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.
|
T3541 |
CC-115
|
1228013-15-7
|
86.79%
|
|
CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM).
|
T4199 |
Desmethyl-VS-5584
|
1246535-95-4
|
100%
|
|
Desmethyl-VS-5584 is a dimethyl analog of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
|